New modular shoulder implant aims to improve outcomes in tough revision surgeries

NCT ID NCT03270982

Ongoing Disease control Sponsor: Zimmer Biomet Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new modular shoulder replacement system in 105 people who need complex revision surgery due to joint disease, trauma, or cancer. The device can replace part or all of the upper arm bone. Researchers are tracking how long the implant lasts and how well patients can use their arm afterward.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Comprehensive Segmental Revision System (a modular shoulder replacement device)
What this could lead to: If successful, this device could provide a more durable and functional option for people needing complex shoulder revision surgery.
What could go wrong: This is an early-stage study with only 105 participants, so results may not apply to everyone. Device failure or complications like infection are possible risks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AVASCULAR NECROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

avascular necrosis injury neoplasm neurodegenerative disease osteoarthritis rheumatoid arthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DEGENERATIVE DISEASE ONCOLOGY REVISION SURGERY RHEUMATOID ARTHRITIS TRAUMA

Contacts and locations

Locations

Department of Orthopedic Surgery, Rigshospitalet University of Copenhagen

Copenhagen, Denmark
Nova Scotia Health Authority

Halifax, Nova Scotia, B3H-1796, Canada
Royal Gwent Hospital

Newport, Wales, NP20 2UB, United Kingdom
Royal Liverpool University Hospital

Liverpool, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.